Space Stocks Slide as Blue Origin Rocket Failure and SpaceX Valuation Concerns Weigh on Sector SBUX Q1 2026 Earnings EPS Beats Estimates by 142 Revenue Unreported Stock Dips 13 Sarepta Therapeutics Maps 2026 Priorities from Strong Cash Position